These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31900195)

  • 21. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes.
    Asadpour A; Yahaya BH; Bicknell K; Cottrell GS; Widera D
    Stem Cell Res Ther; 2023 May; 14(1):111. PubMed ID: 37138298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
    Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
    Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine.
    Gugerell A; Sorgenfrey D; Laggner M; Raimann J; Peterbauer A; Bormann D; Suessner S; Gabriel C; Moser B; Ostler T; Mildner M; Ankersmit HJ
    Blood Transfus; 2020 Jan; 18(1):30-39. PubMed ID: 30865581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unbiased and quantitative proteomics reveals highly increased angiogenesis induction by the secretome of mesenchymal stromal cells isolated from fetal rather than adult skin.
    Gaetani M; Chinnici CM; Carreca AP; Di Pasquale C; Amico G; Conaldi PG
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e949-e961. PubMed ID: 28102936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potency Assays for Mesenchymal Stromal Cell Secretome-Based Products for Tissue Regeneration.
    Sagaradze G; Monakova A; Efimenko A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pericyte secretome: Potential impact on regeneration.
    Gaceb A; Barbariga M; Özen I; Paul G
    Biochimie; 2018 Dec; 155():16-25. PubMed ID: 29698670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretomes derived from osteogenically differentiated jaw periosteal cells inhibit phenotypic and functional maturation of CD14
    Cen W; Umrath F; Salgado AJ; Reinert S; Alexander D
    Front Immunol; 2022; 13():1024509. PubMed ID: 36700194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Application of Cell Secretomes in Cutaneous Wound Healing.
    Bormann D; Gugerell A; Ankersmit HJ; Mildner M
    J Invest Dermatol; 2023 Jun; 143(6):893-912. PubMed ID: 37211377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity.
    Castiglia S; Adamini A; Rustichelli D; Castello L; Mareschi K; Pinnetta G; Leone M; Mandese A; Ferrero I; Mesiano G; Fagioli F
    J Transl Med; 2018 Aug; 16(1):237. PubMed ID: 30157948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges of manufacturing mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine.
    Wiest EF; Zubair AC
    Cytotherapy; 2020 Nov; 22(11):606-612. PubMed ID: 32532592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards standardization of human adipose-derived stromal cells secretomes.
    Pinheiro-Machado E; Getova VE; Harmsen MC; Burgess JK; Smink AM
    Stem Cell Rev Rep; 2023 Oct; 19(7):2131-2140. PubMed ID: 37300663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access.
    Giovannelli L; Bari E; Jommi C; Tartara F; Armocida D; Garbossa D; Cofano F; Torre ML; Segale L
    Bioact Mater; 2023 Nov; 29():16-35. PubMed ID: 37456581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upgrading Monocytes Therapy for Critical Limb Ischemia Patient Treatment: Pre-Clinical and GMP-Validation Aspects.
    Rusconi G; Cusumano G; Mariotta L; Canevascini R; Gola M; Gornati R; Soldati G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation.
    Laggner M; Copic D; Nemec L; Vorstandlechner V; Gugerell A; Gruber F; Peterbauer A; Ankersmit HJ; Mildner M
    EBioMedicine; 2020 May; 55():102774. PubMed ID: 32403085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the potential of the secretomes of cardiac resident stromal cells and fibroblasts.
    Lino JB; Robert AW; Stimamiglio MA; de Aguiar AM
    IUBMB Life; 2023 Mar; 75(3):196-206. PubMed ID: 34590780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease.
    Driscoll J; Patel T
    J Gastroenterol; 2019 Sep; 54(9):763-773. PubMed ID: 31270691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts.
    Niada S; Giannasi C; Magagnotti C; Andolfo A; Brini AT
    J Proteomics; 2021 Feb; 232():104069. PubMed ID: 33309826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein and Molecular Characterization of a Clinically Compliant Amniotic Fluid Stem Cell-Derived Extracellular Vesicle Fraction Capable of Accelerating Muscle Regeneration Through Enhancement of Angiogenesis.
    Mellows B; Mitchell R; Antonioli M; Kretz O; Chambers D; Zeuner MT; Denecke B; Musante L; Ramachandra DL; Debacq-Chainiaux F; Holthofer H; Joch B; Ray S; Widera D; David AL; Huber TB; Dengjel J; De Coppi P; Patel K
    Stem Cells Dev; 2017 Sep; 26(18):1316-1333. PubMed ID: 28679310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a Vimentin
    Cooper TT; Sherman SE; Bell GI; Ma J; Kuljanin M; Jose SE; Lajoie GA; Hess DA
    Stem Cells; 2020 May; 38(5):666-682. PubMed ID: 31904137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.